Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

DSIP

Emideltide, DSIP nonapeptide, Delta sleep-inducing peptide

Quick Stats
Studies 458
Trials 82
Score 2
1999 pubmed

Regulation by delta-sleep-inducing peptide of the neurochemical changes in the brain associated with dopaminergic system hyperactivity.

Gershtein. L M LM; Dovedova. E L EL

Key Findings

  • DSIP (30 µg/kg) was given as a single injection to rats with chronic dopamine system over‑activation.
  • It altered markers of both the serotonin system (MAO‑A, 5‑HT, 5‑HIAA) and the dopamine system (MAO‑B, DA, NA, HVA) in the cortex and caudate.
  • The peptide’s corrective effects differed depending on whether L‑DOPA or amphetamine was used to induce dopamine hyperactivity, suggesting a role for serotonin activation in balancing the brain’s response.

Practical Outcomes

  • The study hints that DSIP might help rebalance brain chemistry when dopamine is overly active, but it’s an animal study with a single dose and no human data. For biohackers, there’s no clear protocol, dosage, or safety information yet, so it’s more of a scientific curiosity than a ready‑to‑use supplement.

Summary

In rats that were given drugs to over‑activate dopamine (like L‑DOPA or amphetamine), a single low dose of delta‑sleep‑inducing peptide (DSIP) changed brain chemistry, especially boosting serotonin‑related activity, which seemed to help normalize the dopamine‑driven disturbances.

Abstract

The influence of a single injection of "delta-sleep-inducing peptide" (DSIP; 30 microg/kg body weight) on neurochemical parameters of rats' brain was studied under the conditions of chronic administration of dopamine analogs inducing DA-system hyperactivity - 50 mg/kg body weight of L-DOPA for 30 days or 2,5 mg/kg body weight of amphetamine for 21 days. The parameters of serotonergic system (MAO A activity, 5-HT, and 5-HIAA contents) and of dopaminergic system (MAO B activity, DA, NA, and HVA contents) were investigated in the cortex and caudate nucleus of control, DA or amphetamine, and DSIP receiving rats. Changes caused by the two DA-system activating drugs had both similarities and differences, and the corrective action of DSIP also had certain peculiarities depending on the pharmacological preparation used for the induction of DA-system hyperactivity and on the investigated brain structure. It is supposed that DSIP action might be based on the activation of serotonergic system that ensures the adaptive behavior of the animals.

Study Information

Provider

pubmed

Year

1999

DOI

10.1023/a:1020760303553